Advanced search
Publication Cover
Journal of Receptors and Signal Transduction Volume 40, 2020 - Issue 3
Submit an article Journal homepage
74
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Fibroblast growth factor receptor-like-1: a new therapeutic target and unfavorable prognostic indicator for rectal adenocarcinoma

Ru-Zhen JiaDepartment of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, PR China; View further author information
,
Ji-Zhun ZhangDepartment of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, PR ChinaView further author information
,
Chang-Qing JingDepartment of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, PR ChinaView further author information
,
Chen-Sheng LiDepartment of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, PR ChinaView further author information
&
Hong-Qing ZhuoDepartment of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, PR ChinaCorrespondence[email protected]
View further author information
Pages 257-263 | Received 15 Oct 2019, Accepted 14 Feb 2020, Published online: 26 Feb 2020

References

  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
  • National Cancer Institute. Cancer Stat Facts: colorectal cancer; 2018 [cited 2020 Feb 19]. Available from: https://seer.cancer.gov/statfacts/html/colorect.html.
  • Siegel RL, Miller K, Jemal DA. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
  • Lee L, Kelly J, Nassif GJ, et al. Defining the learning curve for transanal total mesorectal excision for rectal adenocarcinoma. Surg Endosc. 2018
  • Pettit C, Webb A, Walston S, et al. MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma. Oncotarget. 2018;9(48):28951–28964.
  • Van Wickle JD, Paulson ES, Landry JC, et al. Adaptive radiation dose escalation in rectal adenocarcinoma: a review. J Gastrointest Oncol. 2017;8(5):902–914.
  • Ahmed S, Eng C. Role of chemotherapy in the neoadjuvant/adjuvant setting for patients with rectal adenocarcinoma undergoing chemoradiotherapy and surgery or radiotherapy and surgery. Curr Oncol Rep. 2018;20(1):3.
  • Tan BR, Thomas F, Myerson RJ, et al. Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma. JCO. 2011;29(7):875–883.
  • Tai H, Wu Z, Sun S, et al. FGFRL1 promotes ovarian cancer progression by crosstalk with hedgehog signaling. J Immunol Res. 2018;2018:1–11.
  • Trueb B. Biology of FGFRL1, the fifth fibroblast growth factor receptor. Cell Mol Life Sci. 2011;68(6):951–964.
  • Takei Y, Matsumura T, Watanabe K, et al. FGFRL1 deficiency reduces motility and tumorigenic potential of cells derived from oesophageal squamous cell carcinomas. Oncol Lett. 2018;16:809–814.
  • Ornitz DM, Itoh N. The fibroblast growth factor signaling pathway. Wires Dev Biol . 2015;4(3):215–266.
  • Tsuchiya S, Fujiwara T, Sato F, et al. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1. J Biol Chem. 2011;286(1):420–428. ).
  • Yang X, Shi L, Yi C, et al. MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1. Am J Cancer Res. 2017;7(8):1738–1753.
  • Liu X, Zhang C, Wang C, et al. miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1. Oncol Lett. 2018;16:2229–2236.
  • Samanta DS, Almo C. Nectin family of cell-adhesion molecules: structural and molecular aspects of function and specificity. Cell Mol Life Sci. 2015;72(4):645–658.
  • Zhuang L, Steinberg F, Trueb B. Receptor FGFRL1 acts as a tumor suppressor in nude mice when overexpressed in HEK 293 Tet-On cells. Oncol Lett. 2016;12(6):4524–4530.
  • Yang X, Steinberg F, Zhuang L, et al. Receptor FGFRL1 does not promote cell proliferation but induces cell adhesion. Int J Mol Med. 2016;38(1):30–38.
  • Rühlmann F, Windhof-Jaidhauser IM, Menze C, et al. The prognostic capacities of CBP and p300 in locally advanced rectal cancer. World J Surg Oncol. 2019;17(1):224–224.
  • Borland CZ, Schutzman JL, Stern MJ. Fibroblast growth factor signaling in Caenorhabditis elegans. Bioessays. 2001;23(12):1120–1130.
  • Gerber SD, Steinberg F, Beyeler M, et al. The murine Fgfrl1 receptor is essential for the development of the metanephric kidney. Dev Biol. 2009;335(1):106–119.
  • Kim I, Moon S, Yu K, et al. A novel fibroblast growth factor receptor-5 preferentially expressed in the pancreas(1). Biochim Biophys Acta. 2001;1518(1–2):152–156.
  • Trueb B, Taeschler S. Expression of FGFRL1, a novel fibroblast growth factor receptor, during embryonic development. Int J Mol Med. 2006;17:617–620.
  • Amann R, Wyder S, Slavotinek AM, et al. The FgfrL1 receptor is required for development of slow muscle fibers. Dev Biol. 2014;394(2):228–241.
  • Silva PN, Altamentova SM, Kilkenny DM, et al. Fibroblast growth factor receptor like-1 (FGFRL1) interacts with SHP-1 phosphatase at insulin secretory granules and induces beta-cell ERK1/2 protein activation. J Biol Chem. 2013;288(24):17859–17870.
  • Davis M, Clarke S. Influence of microRNA on the maintenance of human iron metabolism. Nutrients. 2013;5(7):2611–2628.
  • Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22:153–183.
  • Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009;8(3):235–253.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.